Ocular Pathology / Ocular Oncology and Tumors

FP0301 : Outcomes of Ruthenium Plaque Brachytherapy in OSSN with Corneal Stromal and Scleral Invasion

FP0441 : Artificial Intelligence and Machine Learning in Ocular Oncology: Retinoblastoma

FP1172 : ASSOCIATION OF P53 GENE MUTATION IN VARIOUS EYELID CARCINOMAS

FP1237 : Immune Profiling of Covid Associated Rhino Orbito Cerebral Mucormycosis (Ca ROCM)

FP1559 : Multimodal Management in Orbital Rhabdomyosarcoma can Optimise Eye and Life Salvage

FP1583 : Correlation of Risk Factors & Adjuvant Therapy in the Era of Secondary Enucleation in Retinoblastoma

FP1761 : To evaluate classification systems of retinoblastoma in prognosticating survival and eye salvage.

FP1793 : TITLE: Intra-arterial chemotherapy in refractory and advance retinoblastoma: A game changer.

FP1806 : Prognostic significance of survivin (BIRC5) in retinoblastoma

FP1930 : Ruthenium 106 episcleral brachytherapy in ocular tumours-Experience from a tertiary centre

Keynote Address ( 10′ ) : AIOS – Ocular Pathology / Ocular Oncology and Tumors Award – ORBITAL MASS AS PRESENTING SIGN OF UNDERLYING MALIGNANCY: CLINICAL, PATHOLOGICAL FEATURES & OUTCOMES – DR. AKSHAY NAIR (N12639)

STATE BEST PAPER : Uttarakhand State Ophthalmological Society : A Leopard Cannot Change Its Spots – DR. SHWETA PARAKH (P16625)